If you’ve read all the warnings and still want to jump into some of the top penny stocks to buy, focus on the key fundamentals. That includes its earnings numbers, business models, product pipelines and what market they’re part of. You’ll also want to pay close attention to volume, especially volume spikes. That’s because volume often precedes price. In addition, you’ll also want to see if the volume is being supported by news. Or you’ll get what we just saw with Zapp Electric (NASDAQ:ZAPP). InvestorPlace - Stock Market News, Stock Advice & Trading Tips Over the last few days, ZAPP ran from about $2 to $19.10 on heavy volume — but no news. On July 2, it traded at $2.04 and saw volume spike to 35.2 million, as compared to average volume of 7.2 million. On July 3, volume jumped to 25.5 million. By July 5, it was up to 50.3 million. Then by July 8, volume soared to 105 million. And by July 9, volume was up 45 million. Now, as volume fades, the stock is starting to pull back. While it was fun to watch, it won’t end well — especially for the stock-chasing bag holders. Here are a few “safer” penny stocks to buy instead. Kazia Therapeutics (KZIA) medicine research, pharmaceutical background, LJPC stock Source: Sisacorn / Shutterstock.com Keep an eye on penny stocks to buy such as Kazia Therapeutics (NASDAQ:KZIA). Even after exploding from 20 cents to a high of $1.08, it could push aggressively higher. All after it posted positive Phase 2/3 results for its drug paxalisib in the treatment of glioblastoma, which is a malignant tumor affecting the brain or spine. The study, called GBM-AGILE, showed a median overall survival of 14.77 months for paxalisib-treated patients, as compared to 13.84 months for those given the standard of care. With that, the company said it will request a meeting with the U.S. FDA to see if it can get accelerated approval. As noted by Kazia CEODr. John Friend, “We are excited to have shown a 3.8-month improvement in overall survival, an approximate 33% improvement, for newly diagnosed unmethylated patients with GBM compared to the concurrent standard of care arm. Having comparable Overall Survival data across two independent studies is a compelling outcome in this difficult-to-treat glioblastoma population.” Curaleaf Holdings (CURLF) scientist checking organic hemp wild plants in a cannabis weed commercial greenhouse. Concept of herbal alternative medicine, cbd oil, pharmaceutical industry. Cannabis stocks, FLGC stocks Source: Chokniti-Studio / Shutterstock.com At a bit over $4, Curaleaf Holdings (OTCMKTS:CURLF) is a strong buy on three key cannabis catalysts. As I noted on July 8, “We already know 88% of Americans want legalization, which the current candidates should use to their advantage for votes. We know cannabis will be rescheduled as a Schedule III drug at some point. And we know that Florida will vote on legalization.” If Florida votes for legalization, it could unlock a massive market opportunity. All are potentially powerful catalysts. Helping, according to Curaleaf CEO Matt Darin, “Our unique exposure to the most significant catalysts on the horizon — continued expansion of the NY market, expansion of Pillar 1 in Germany, and adult use in Ohio, Florida and Pennsylvania sets us up for robust growth in 2025 and beyond.” Last trading at around $4.16, I’d use the recent weakness as an opportunity as we near the election. Plug Power (PLUG) In this photo illustration, the Plug Power logo is displayed on a smartphone screen Source: rafapress / Shutterstock.com We can also look at down, but not out shares of hydrogen stock, Plug Power (NASDAQ:PLUG). After finding strong support at around $2.21, PLUG now trades at $3.02 and could push higher. Helping, the company justdeployed 13 hydrogen refueling stations across Europe. While most are still in the commissioning phase, all are expected to be operational this summer. Even better, the company said it saw a “substantial advancement” with its plants in Georgia and Tennessee. It also noted that its Louisiana joint venture with Olin (NYSE:OLN) is on track to see mechanical completion by the end of the third quarter. Plus, it just signed two contracts to deliver basic engineering and design packages for projects in Europe and the U.S. Moreover, when and if we see changes to restrictive 45V industry tax credits, Plug Power and other top hydrogen stocks could race to higher highs. On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks. Read More: Penny Stocks — How to Profit Without Getting Scammed On the date of publication, Ian Cooper did not hold (either directly or indirectly) any positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines. On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article. Ian Cooper, a contributor to InvestorPlace.com, has been analyzing stocks and options for web-based advisories since 1999. More From InvestorPlace Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future” The post From Pennies to Dollars: 3 Sub-$5 Stocks Set to Explode Higher appeared first on InvestorPlace.
From Pennies to Dollars: 3 Sub-$5 Stocks Set to Explode Higher
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...